Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Media planning
Researching and reviewing the most appropriate mediums on which to advertise, and how best to take advantage of their various formats . A Media planner is commonly from an advertising agency or media planning and buying agency. A Media Planner is accountable for choosing the media for advertisement placement for their clients.
Related terms
Key account management, Focus group moderator, Respondent, Feature article, Column inches, Post-testing, Sponsorship, Business plan, Publication planning, Media buyer, Continuing Medical Education (CME), In-house newspaper/magazine, Direct response advertising (DRA), Marketing intelligence, Display advertisement,
COVID-19 Updates and Daily News
Featured jobs
-
Head of Copy
-
£ competitive
- Sanofi and Exscientia agree on a deal worth up to $5.2bn for AI-driven therapies
- Pfizer CEO announces plans to launch Omicron-specific COVID-19 vaccine
- Pfizer expands access to lipid nanoparticle technology in new agreement with Acuitas Therapeutics
- Biogen’s Alzheimer’s treatment Aduhelm limited to clinical trial participants in the US
- BMS and 2seventy bio move away from CAR-T programme
- Amgen’s Lumykras receives conditional marketing authorisation from EC
- Live Webinar: Measuring Vital Health Indicators Through Your Camera
- AstraZeneca's Enhertu receives FDA grant for priority review
- Pfizer’s Cibinqo granted FDA approval for adults with moderate-to-severe atopic dermatitis
- Julie Beeso joins Envision Pharma Group in new Global Director, Professional Development and Engagement role
- Live Webinar: Expanding Access to High-Quality Healthcare
- Vir Biotech launches new research programme for HIV and malaria prevention
- Sanofi and Exscientia agree on a deal worth up to $5.2bn for AI-driven therapies
- Why pharma must get smart in its approach to customer engagement
- Pfizer lifts 2021 guidance as sales of its BioNTech-partnered vaccine continue to climb
- Amgen’s Lumykras receives conditional marketing authorisation from EC
- J&J’s COVID-19 booster shows 85% effectiveness in preventing hospitalisation for COVID-19 in study
- Understanding religious and cultural barriers to clinical trial participation
